BG63116B1 - Метод за получаване на о-(3-амино-2-хидрокси-пропил)- хидроксимови ацилхалогениди - Google Patents
Метод за получаване на о-(3-амино-2-хидрокси-пропил)- хидроксимови ацилхалогениди Download PDFInfo
- Publication number
- BG63116B1 BG63116B1 BG103847A BG10384799A BG63116B1 BG 63116 B1 BG63116 B1 BG 63116B1 BG 103847 A BG103847 A BG 103847A BG 10384799 A BG10384799 A BG 10384799A BG 63116 B1 BG63116 B1 BG 63116B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- formula
- hydroxy
- reaction
- carboxamide oxime
- salt
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- -1 carboxamide oxime Chemical class 0.000 claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 8
- 239000011541 reaction mixture Substances 0.000 claims abstract description 8
- 239000012954 diazonium Substances 0.000 claims abstract description 6
- 150000001989 diazonium salts Chemical group 0.000 claims abstract description 6
- 235000010288 sodium nitrite Nutrition 0.000 claims abstract description 6
- GMWFCJXSQQHBPI-UHFFFAOYSA-N azetidin-3-ol Chemical class OC1CNC1 GMWFCJXSQQHBPI-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 5
- 239000003960 organic solvent Substances 0.000 claims abstract description 5
- 150000001450 anions Chemical class 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 238000002955 isolation Methods 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical class CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 claims abstract description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 150000001266 acyl halides Chemical class 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 4
- 238000006193 diazotization reaction Methods 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 125000001188 haloalkyl group Chemical group 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 230000003472 neutralizing effect Effects 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 125000004076 pyridyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 22
- 238000000926 separation method Methods 0.000 abstract description 4
- 238000006386 neutralization reaction Methods 0.000 abstract description 2
- 150000001298 alcohols Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- FXNSRODXMVUCNJ-ODZAUARKSA-N (z)-but-2-enedioic acid;hydrochloride Chemical compound Cl.OC(=O)\C=C/C(O)=O FXNSRODXMVUCNJ-ODZAUARKSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- SFZULDYEOVSIKM-UHFFFAOYSA-N chembl321317 Chemical class C1=CC(C(=N)NO)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=N)NO)O1 SFZULDYEOVSIKM-UHFFFAOYSA-N 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- AQBMQGDKWIPBRF-UHFFFAOYSA-N n'-hydroxypyridine-3-carboximidamide Chemical compound ON=C(N)C1=CC=CN=C1 AQBMQGDKWIPBRF-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 125000003341 7 membered heterocyclic group Chemical group 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical group C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- RPNGOMBXNOMBCG-BTJKTKAUSA-N (z)-but-2-enedioic acid;n-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride Chemical compound OC(=O)\C=C/C(O)=O.C1CCCCN1CC(O)CON=C(Cl)C1=CC=CN=C1 RPNGOMBXNOMBCG-BTJKTKAUSA-N 0.000 description 1
- YJUUZFWMKJBVFJ-UHFFFAOYSA-N 1,3-dimethylimidazolidin-4-one Chemical compound CN1CN(C)C(=O)C1 YJUUZFWMKJBVFJ-UHFFFAOYSA-N 0.000 description 1
- IGMZDGBNMCELOE-UHFFFAOYSA-N 1-chloro-3-piperidin-1-ylpropan-2-ol Chemical compound ClCC(O)CN1CCCCC1 IGMZDGBNMCELOE-UHFFFAOYSA-N 0.000 description 1
- CBMWZDLWQNWEOJ-UHFFFAOYSA-N 2-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride Chemical compound OC(COC1=NC=CC=C1C(=N)Cl)CN1CCCCC1 CBMWZDLWQNWEOJ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- DAXOEPZCJSADTF-UHFFFAOYSA-N Cl.C1CCCCN1CC(O)CON=C(Cl)C1=CC=CS1 Chemical compound Cl.C1CCCCN1CC(O)CON=C(Cl)C1=CC=CS1 DAXOEPZCJSADTF-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical class NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- NMOVJBAGBXIKCG-UHFFFAOYSA-N n-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride Chemical compound C1CCCCN1CC(O)CON=C(Cl)C1=CC=CN=C1 NMOVJBAGBXIKCG-UHFFFAOYSA-N 0.000 description 1
- UFAFWRGJORGNKN-UHFFFAOYSA-N n-[3-(diethylamino)-2-hydroxypropoxy]pyridine-3-carboximidoyl chloride;hydrochloride Chemical compound Cl.CCN(CC)CC(O)CON=C(Cl)C1=CC=CN=C1 UFAFWRGJORGNKN-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/12—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reactions not involving the formation of oxyimino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/02—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9700699A HU220971B1 (hu) | 1997-04-03 | 1997-04-03 | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
| PCT/HU1997/000082 WO1998043948A1 (en) | 1997-04-03 | 1997-12-05 | Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG103847A BG103847A (en) | 2000-07-31 |
| BG63116B1 true BG63116B1 (bg) | 2001-04-30 |
Family
ID=89994956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103847A BG63116B1 (bg) | 1997-04-03 | 1999-11-02 | Метод за получаване на о-(3-амино-2-хидрокси-пропил)- хидроксимови ацилхалогениди |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US6180787B1 (ja) |
| EP (1) | EP0975585A1 (ja) |
| JP (1) | JP2001521498A (ja) |
| KR (1) | KR20010005943A (ja) |
| CN (1) | CN1251574A (ja) |
| AP (1) | AP9901646A0 (ja) |
| AR (1) | AR012308A1 (ja) |
| AU (1) | AU737994B2 (ja) |
| BG (1) | BG63116B1 (ja) |
| BR (1) | BR9714717A (ja) |
| CA (1) | CA2285360A1 (ja) |
| CO (1) | CO4940491A1 (ja) |
| EA (1) | EA199900899A1 (ja) |
| EE (1) | EE03868B1 (ja) |
| EG (1) | EG22104A (ja) |
| HR (1) | HRP980175A2 (ja) |
| HU (1) | HU220971B1 (ja) |
| ID (1) | ID20016A (ja) |
| IL (1) | IL132048A0 (ja) |
| IS (1) | IS5174A (ja) |
| MA (1) | MA26143A1 (ja) |
| NO (1) | NO312027B1 (ja) |
| NZ (1) | NZ500020A (ja) |
| PE (1) | PE83299A1 (ja) |
| PL (1) | PL336072A1 (ja) |
| SK (1) | SK134899A3 (ja) |
| TN (1) | TNSN98046A1 (ja) |
| TR (1) | TR199902207T2 (ja) |
| TW (1) | TW455573B (ja) |
| UY (1) | UY24945A1 (ja) |
| WO (1) | WO1998043948A1 (ja) |
| YU (1) | YU49499A (ja) |
| ZA (1) | ZA982755B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9900475D0 (en) * | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
| KR20040089102A (ko) | 2002-01-11 | 2004-10-20 | 비오렉스 쿠타토 에쉬 훼레스테 에르테 | 카르복사미딘 유도체 및 혈관 질환의 치료에서의 이들 용도 |
| HUP0303584A3 (en) | 2003-10-30 | 2009-12-28 | Cytrx Corp | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| JP5995988B2 (ja) * | 2011-12-23 | 2016-09-21 | アクゾ ノーベル ケミカルズ インターナショナル ベスローテン フエンノートシャップＡｋｚｏ Ｎｏｂｅｌ Ｃｈｅｍｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｂ．Ｖ． | 化合物 |
| BR112014028700B1 (pt) * | 2012-06-14 | 2021-01-05 | Alcon Inc. | copolímero e monômero vinílico contendo azetidínio, lente de contato de silicone hidrogel e métodos de produção da mesma |
| CN103804309B (zh) * | 2012-11-09 | 2019-08-02 | 广州喜鹊医药有限公司 | 一种氯肟类化合物及其制备方法和在制药中的应用 |
| IL303026A (en) | 2020-11-19 | 2023-07-01 | Zevra Denmark As | Processes for preparing arimoclomol citrate and its intermediates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU207305B (en) * | 1988-03-23 | 1993-03-29 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoxime derivatives |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| HUT54347A (en) * | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
-
1997
- 1997-04-03 HU HU9700699A patent/HU220971B1/hu not_active IP Right Cessation
- 1997-12-05 WO PCT/HU1997/000082 patent/WO1998043948A1/en not_active Application Discontinuation
- 1997-12-05 KR KR1019997009020A patent/KR20010005943A/ko not_active Application Discontinuation
- 1997-12-05 BR BR9714717-6A patent/BR9714717A/pt not_active Application Discontinuation
- 1997-12-05 CA CA002285360A patent/CA2285360A1/en not_active Abandoned
- 1997-12-05 AU AU54055/98A patent/AU737994B2/en not_active Ceased
- 1997-12-05 PL PL97336072A patent/PL336072A1/xx unknown
- 1997-12-05 TR TR1999/02207T patent/TR199902207T2/xx unknown
- 1997-12-05 JP JP54132298A patent/JP2001521498A/ja active Pending
- 1997-12-05 EP EP97947819A patent/EP0975585A1/en not_active Withdrawn
- 1997-12-05 CN CN97182087A patent/CN1251574A/zh active Pending
- 1997-12-05 SK SK1348-99A patent/SK134899A3/sk unknown
- 1997-12-05 EA EA199900899A patent/EA199900899A1/ru unknown
- 1997-12-05 EE EEP199900438A patent/EE03868B1/xx not_active IP Right Cessation
- 1997-12-05 NZ NZ500020A patent/NZ500020A/en unknown
- 1997-12-05 US US09/402,267 patent/US6180787B1/en not_active Expired - Fee Related
- 1997-12-05 AP APAP/P/1999/001646A patent/AP9901646A0/en unknown
- 1997-12-15 YU YU49499A patent/YU49499A/sh unknown
-
1998
- 1998-03-30 MA MA25016A patent/MA26143A1/fr unknown
- 1998-03-31 EG EG36098A patent/EG22104A/xx active
- 1998-04-01 ZA ZA982755A patent/ZA982755B/xx unknown
- 1998-04-02 AR ARP980101495A patent/AR012308A1/es not_active Application Discontinuation
- 1998-04-02 TN TNTNSN98046A patent/TNSN98046A1/fr unknown
- 1998-04-02 UY UY24945A patent/UY24945A1/es not_active IP Right Cessation
- 1998-04-02 PE PE1998000247A patent/PE83299A1/es not_active Application Discontinuation
- 1998-04-03 CO CO98018891A patent/CO4940491A1/es unknown
- 1998-04-03 HR HRP9700699A patent/HRP980175A2/hr not_active Application Discontinuation
- 1998-04-03 ID IDP980507A patent/ID20016A/id unknown
- 1998-04-07 TW TW087105087A patent/TW455573B/zh not_active IP Right Cessation
-
1999
- 1999-09-10 IS IS5174A patent/IS5174A/is unknown
- 1999-09-23 IL IL13204899A patent/IL132048A0/xx unknown
- 1999-09-23 NO NO19994628A patent/NO312027B1/no not_active IP Right Cessation
- 1999-11-02 BG BG103847A patent/BG63116B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3107672B2 (ja) | ５−（置換メチル）−２，３−ピリジンジカルボン酸の製造に有用な５，６−ジ置換−３−ピリジルメチルアンモニウムハライド化合物 | |
| EP0023097B1 (en) | De-arylmethylation of n-mono- or n-diarylmethyl-beta-lactams; novel azetizinones having anti-bacterial activity | |
| BG63116B1 (bg) | Метод за получаване на о-(3-амино-2-хидрокси-пропил)- хидроксимови ацилхалогениди | |
| US4032559A (en) | N,2-dicyanoacetimidates | |
| US4587356A (en) | Process for the production of nuclear substituted cinnamoylanthranilic acid derivatives | |
| US4292431A (en) | Process for the production of hydroxymethylimidazoles | |
| CN108727323B (zh) | 一种氮杂环卡宾催化合成三氟甲基取代高异黄酮类化合物的方法 | |
| US4091095A (en) | Phosphinyl compounds | |
| US2981735A (en) | New piperazine derivatives | |
| MXPA99009046A (en) | Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides | |
| CZ336399A3 (cs) | Způsob přípravy halogenidů 0-(3-amino-2- hydroxypropyl)hydroxamové kyseliny | |
| JP2612161B2 (ja) | ジベンゾチエピン誘導体の製造法 | |
| SU561513A3 (ru) | Способ получени производных пиперазина или их солей | |
| JPH01207276A (ja) | 新規なプロパン誘導体 | |
| KR100252462B1 (ko) | ο-(클로로메틸)벤조산에스테르유도체의제조방법 | |
| JPH023672A (ja) | ２，６‐ジエチルアニリン誘導体およびその製法 | |
| CA1120493A (en) | Process for producing 4'-(2-carboxy-ethyl)phenyl trans-4-aminomethylcyclohexanecarboxylate or the acid-addition salts thereof and intermediates for producing the same | |
| KR880001850B1 (ko) | 5-플루오로 피리돈 유도체의 제조방법 | |
| CA1207796A (en) | Intermediates for the preparation of 4-phenyl-1,3- benzodiazepins and methods for preparing the intermediates | |
| US6127537A (en) | Method for preparing 3-amino-1,2-propandiol derivatives | |
| JPH03200747A (ja) | Ｎ−メチル−４−ｔ−ブチルベンジルアミンの製造法 | |
| JPS63216861A (ja) | ４−ハイドロオキシインドリン類の製造法 | |
| JPH0150219B2 (ja) | ||
| JPH041736B2 (ja) | ||
| IL120964A (en) | PROCESS FOR THE PREPARATION OF ALKYL 4, 5-DIHYDRO -gamma, 5-DIOXO-2-ARYL -4- OXAZOLEBUTANOATES AND THEIR USE AS PRECURSORS FOR delta-AMINOLEVULINIC ACID HYDROCHLORIDE (ALA) PRODUCTION |